Page last updated: 2024-08-17

carbostyril and Hepatitis A

carbostyril has been researched along with Hepatitis A in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bugnon, S; Godinho, R; Gracin, T; Tataw, J1
Abraham, OC; Balaji, V; George, IA; Kapil, A; Karthik, R; Mitra, S1

Other Studies

2 other study(ies) available for carbostyril and Hepatitis A

ArticleYear
Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya® (EVG/COBI/FTC/TAF) and simvastatin; a case report.
    BMC nephrology, 2019, 02-26, Volume: 20, Issue:1

    Topics: Acute Kidney Injury; Anti-HIV Agents; Cobicistat; Drug Combinations; Drug Interactions; Dyslipidemias; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine; Hepatitis A; Hepatitis C; HIV Infections; Humans; Hypolipidemic Agents; Liver Function Tests; Male; Middle Aged; Quinolones; Renal Dialysis; Rhabdomyolysis; Simvastatin; Tenofovir; Treatment Outcome

2019
Quinolone-resistant Salmonella enterica Serovar typhi presenting as acute fulminant hepatitis.
    The Journal of the Association of Physicians of India, 2009, Volume: 57

    Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Bacterial; Hepatitis A; Humans; Liver Failure, Acute; Male; Microbial Sensitivity Tests; Quinolones; Salmonella typhi; Typhoid Fever

2009